Vaccinex Stock Market Value
| VCNX Stock | USD 3.62 0.02 0.56% |
| Symbol | Vaccinex |
Vaccinex Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaccinex. If investors know Vaccinex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaccinex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.42 | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.81) | Return On Assets (4.96) | Return On Equity (7.59) |
The market value of Vaccinex is measured differently than its book value, which is the value of Vaccinex that is recorded on the company's balance sheet. Investors also form their own opinion of Vaccinex's value that differs from its market value or its book value, called intrinsic value, which is Vaccinex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaccinex's market value can be influenced by many factors that don't directly affect Vaccinex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaccinex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vaccinex 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaccinex's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaccinex.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in Vaccinex on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding Vaccinex or generate 0.0% return on investment in Vaccinex over 270 days. Vaccinex is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through... More
Vaccinex Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaccinex's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaccinex upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 54.95 | |||
| Value At Risk | (14.00) | |||
| Potential Upside | 11.11 |
Vaccinex Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaccinex's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaccinex's standard deviation. In reality, there are many statistical measures that can use Vaccinex historical prices to predict the future Vaccinex's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (1.50) | |||
| Treynor Ratio | (0.22) |
Vaccinex Backtested Returns
Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0193, which indicates the firm had a -0.0193% return per unit of risk over the last 3 months. Vaccinex exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaccinex's Coefficient Of Variation of (6,855), variance of 75.0, and insignificant Risk Adjusted Performance to confirm the risk estimate we provide. The entity has a beta of 0.61, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vaccinex's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vaccinex is expected to be smaller as well. At this point, Vaccinex has a negative expected return of -0.17%. Please make sure to validate Vaccinex's value at risk, as well as the relationship between the rate of daily change and relative strength index , to decide if Vaccinex performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Vaccinex has average predictability. Overlapping area represents the amount of predictability between Vaccinex time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaccinex price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Vaccinex price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 2.35 |
Vaccinex lagged returns against current returns
Autocorrelation, which is Vaccinex stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vaccinex's stock expected returns. We can calculate the autocorrelation of Vaccinex returns to help us make a trade decision. For example, suppose you find that Vaccinex has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vaccinex regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vaccinex stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vaccinex stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vaccinex stock over time.
Current vs Lagged Prices |
| Timeline |
Vaccinex Lagged Returns
When evaluating Vaccinex's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vaccinex stock have on its future price. Vaccinex autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vaccinex autocorrelation shows the relationship between Vaccinex stock current value and its past values and can show if there is a momentum factor associated with investing in Vaccinex.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Vaccinex Stock Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.